loading...| Preferred Name | Enfuvirtide | |
| Synonyms |
|
|
| Definitions |
A short polypeptide with activity against human immunodeficiency virus (HIV). Enfuvirtide binds to the first heptad-repeat (HR1) in the gp41 viral envelope glycoprotein, thereby preventing conformational changes required for fusion of viral and cellular membranes and preventing the virus from entering a host cell. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C2105 |
|
| CAS_Registry |
159519-65-0 |
|
| CHEBI_ID |
CHEBI:608828 |
|
| Chemical_Formula |
C204H301N51O64 |
|
| code |
C2105 |
|
| Contributing_Source |
FDA |
|
| definition |
A short polypeptide with activity against human immunodeficiency virus (HIV). Enfuvirtide binds to the first heptad-repeat (HR1) in the gp41 viral envelope glycoprotein, thereby preventing conformational changes required for fusion of viral and cellular membranes and preventing the virus from entering a host cell. |
|
| FDA_UNII_Code |
19OWO1T3ZE |
|
| in_subset | ||
| label |
Enfuvirtide |
|
| Legacy Concept Name |
T-20 |
|
| Preferred_Name |
Enfuvirtide |
|
| prefixIRI |
NCIT:C2105 |
|
| prefLabel |
Enfuvirtide |
|
| Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance |
|
| UMLS_CUI |
C0537439 |
|
| subClassOf |